Figure 2

Preclinical studies for a cationic liposome formulation containing Il-2 Intended for the treatment of Human Tumors

Maria Teresa Corona-Ortega*, Arturo Valle-Mendiola, Leonor Aguilar-Santelises, Araceli Garcia del Valle, Rosalva Rangel-Corona and Benny Weiss-Steider

Published: 29 October, 2018 | Volume 2 - Issue 1 | Pages: 051-059

apps-aid1010-g002

Figure 2:

Stability of frozen liposomes containing IL-2 as a function of time. A: Integrity evaluated by flow cytometry as the percentage size of liposomes as compared to the control that was taken as 100%; B: Percentage of biological activity of IL-2 contained in liposomes evaluated by an analytical assay as compared to a control taken as 100%. Media: Trehalose/glycerol; CV: variation coefficient.

Read Full Article HTML DOI: 10.29328/journal.apps.1001010 Cite this Article Read Full Article PDF

More Images

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More